Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

FOLFOXIRI Plus Panitumumab In Kras and Braf Wild-Type Metastatic Colorectal Cancer (TRIP)

This study has been completed.
Information provided by (Responsible Party):
Gruppo Oncologico del Nord-Ovest Identifier:
First received: May 19, 2011
Last updated: March 10, 2015
Last verified: March 2015
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Estimated Study Completion Date: No date given
  Primary Completion Date: October 2011 (Final data collection date for primary outcome measure)